title: Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
abstract: We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia.
authors.affiliation: Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA. tzesiewi@hsc.usf.edu
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Zesiewicz
authors.forename: Elan D
authors.initials: ED
authors.lastname: Louis
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Sullivan
authors.forename: Martin
authors.initials: M
authors.lastname: Menkin
authors.forename: Peter B
authors.initials: PB
authors.lastname: Dunne
authors.forename: Robert A
authors.initials: RA
authors.lastname: Hauser
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008538:Meige Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000077287:Levetiracetam; D010889:Piracetam